Healthcare provider profile · identity verified

Christopher Mark Pogodzinski, MD

Family Practice · NAZARETH, PA · NPI 1124025952

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	536	129
Amlodipine Besylate	Amlodipine Besylate	488	121
Levothyroxine Sodium	Levothyroxine Sodium	358	77
Gabapentin	Gabapentin	222	51
Metoprolol Succinate	Metoprolol Succinate	214	52
Lisinopril	Lisinopril	211	56
Pantoprazole Sodium	Pantoprazole Sodium	205	46
Rosuvastatin Calcium	Rosuvastatin Calcium	190	49
Metformin Hcl	Metformin Hcl	173	46
Pravastatin Sodium	Pravastatin Sodium	173	41
Omeprazole	Omeprazole	169	48
Tamsulosin Hcl	Tamsulosin Hcl	159	34
Sertraline Hcl	Sertraline Hcl	154	39
Furosemide	Furosemide	143	38
Losartan Potassium	Losartan Potassium	137	38
Metoprolol Tartrate	Metoprolol Tartrate	137	30
Lorazepam	Lorazepam	127	30
Eliquis	Apixaban	110	26
Simvastatin	Simvastatin	108	26
Fluticasone Propionate	Fluticasone Propionate	106	40
Escitalopram Oxalate	Escitalopram Oxalate	98	22
Prednisone	Prednisone	98	60
Valsartan	Valsartan	97	28
Potassium Chloride	Potassium Chloride	95	23
Duloxetine Hcl	Duloxetine Hcl	93	22
Alprazolam	Alprazolam	92	29
Albuterol Sulfate Hfa	Albuterol Sulfate	87	27
Hydrochlorothiazide	Hydrochlorothiazide	86	27
Trazodone Hcl	Trazodone Hcl	75	17
Citalopram Hbr	Citalopram Hydrobromide	74	17
Tramadol Hcl	Tramadol Hcl	72	26
Jardiance	Empagliflozin	70	13
Synthroid	Levothyroxine Sodium	67	12
Glimepiride	Glimepiride	62	15
Meloxicam	Meloxicam	61	16
Famotidine	Famotidine	60	15
Repaglinide	Repaglinide	58	12
Clopidogrel	Clopidogrel Bisulfate	57	14
Clonazepam	Clonazepam	54	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	12
Montelukast Sodium	Montelukast Sodium	52	14
Spironolactone	Spironolactone	52	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	52	11
Allopurinol	Allopurinol	50	12
Zolpidem Tartrate	Zolpidem Tartrate	50	14
Azithromycin	Azithromycin	46	38
Bupropion Xl	Bupropion Hcl	46	14
Ozempic	Semaglutide	45	11
Ondansetron Hcl	Ondansetron Hcl	42	suppressed
Cephalexin	Cephalexin	41	34
Amoxicillin	Amoxicillin	40	33
Buspirone Hcl	Buspirone Hcl	40	suppressed
Carvedilol	Carvedilol	40	suppressed
Atenolol	Atenolol	39	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Warfarin Sodium	Warfarin Sodium	36	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	30
Glipizide Er	Glipizide	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	19
Ezetimibe	Ezetimibe	32	suppressed
Torsemide	Torsemide	32	suppressed
Finasteride	Finasteride	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Ibandronate Sodium	Ibandronate Sodium	27	13
Klor-Con M20	Potassium Chloride	27	suppressed
Novolog Flexpen	Insulin Aspart	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	26	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Xarelto	Rivaroxaban	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Lactulose	Lactulose	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Desloratadine	Desloratadine	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Topiramate	Topiramate	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Glyxambi	Empagliflozin/Linagliptin	13	suppressed
Livalo	Pitavastatin Calcium	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Cefdinir	Cefdinir	11	11
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Naproxen	Naproxen	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error